Ewing sarcoma from molecular biology to the clinic

In Europe, with an incidence of 7.5 cases per million, Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children, adolescents and young adults, after osteosarcoma. Since the 1980s, conventional treatment has been based on the use of neoadjuvant and adjuvant chemotherapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupuy, Maryne, Lamoureux, François, Mullard, Mathilde, Postec, Anaïs, Regnier, Laura, Baud’huin, Marc, Georges, Steven, Brounais-Le Royer, Bénédicte, Ory, Benjamin, Rédini, Françoise, Verrecchia, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518617/
https://www.ncbi.nlm.nih.gov/pubmed/37752913
http://dx.doi.org/10.3389/fcell.2023.1248753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518617/
https://www.ncbi.nlm.nih.gov/pubmed/37752913
http://dx.doi.org/10.3389/fcell.2023.1248753

Ejemplares similares